Better Long-Term Outcomes With Uterine Artery Embolization vs MR-Guided Ultrasound for Uterine Fibroids
By Denise Baez
SAN ANTONIO, Tex -- November 5, 2017 -- Uterine artery embolization (UAE) is associated with improved long-term outcomes, compared with magnetic resonance (MR)-guided focused ultrasound for symptomatic uterine fibroids, according to a study presented here at the 2017 Annual Meeting of the American Society for Reproductive Medicine (ASRM).
Women who underwent MR-guided focused ultrasound for symptomatic uterine fibroids were more likely to have a second procedure for their symptoms compared with women who underwent UAE.
At 2 years, the cumulative incidence of a second fibroid procedure for women undergoing MR-guided focused ultrasound was 24% compared with 12% for women who underwent UAE (hazard ratio [HR] = 2.8; 95% confidence interval [CI], 1.1-7.8).
At baseline, symptom severity scores were 53.9 in the MR-guided ultrasound group and 53.1 in the UAE group. At 6 months post intervention, scores were 31.3 versus 13.2 (P< .001), respectively, and at 24 months, scores were 32.1 and 14.2 (P = .04).
At baseline, health-related quality of life (HRQL) scores were 52.5 in the MR-guided ultrasound group and 51.0 in the UAE group. HRQL scores increased significantly in the UAE group at 6 (91.2 vs 77.0; P = 002) and 24 months (92.4 vs 71.8 (P = .009) after the intervention.
At 2 years, cumulative incidence of menopause was 0% in the ultrasound group, compared with 9% in the UAE group.
“Earlier menopause after UAE may contribute to control of fibroid symptoms, as evidenced by better quality of life scores,” explained Shannon K. Laughlin-Tommaso, MD, Mayo Clinic, Rochester, Minnesota.
The FIRSTT study included 83 premenopausal women (mean age, 44.4 years) with symptomatic uterine fibroids from 2 studies: a randomised trial of UAE versus MR-guided ultrasound and an observational study of women undergoing these procedures but declined randomisation (49 were randomised).
The primary outcome was undergoing a second fibroid procedure for symptoms. Secondary endpoints included menopause and disease-specific quality of life scores.
[Presentation title: Long-Term Outcomes in a Randomized Controlled Trial of Uterine Artery Embolization and MR-Guided Focused Ultrasound: the First Study. Abstract O-61]
DG News saves you time by delivering a short list of medical stories worthy of your time and attention. Our advanced algorithms rank clinical content based on hundreds of data points to surface the most important medical advances impacting your practice each week.